Nighttime Blood Pressure Measured by Home Blood Pressure Monitoring as an Independent Predictor of Cardiovascular Events in General Practice.


Journal

Hypertension (Dallas, Tex. : 1979)
ISSN: 1524-4563
Titre abrégé: Hypertension
Pays: United States
ID NLM: 7906255

Informations de publication

Date de publication:
06 2019
Historique:
pubmed: 23 4 2019
medline: 19 11 2019
entrez: 23 4 2019
Statut: ppublish

Résumé

We developed an innovative automated home blood pressure (BP) monitoring method that measures BP while asleep repeatedly over several days. Our aim was to assess the predictive ability of nighttime BP obtained using the home BP device for incident cardiovascular disease (CVD) in general practice patients. We used data from the nationwide practice-based J-HOP (Japan Morning Surge-Home Blood Pressure) Nocturnal BP Study, which recruited 2545 Japanese with a history of or risk factors for CVD (mean age 63 years; antihypertensive medication use 83%). The associations between nighttime home BPs (measured at 2:00, 3:00, and 4:00 am using validated, automatic, and oscillometric home BP devices) and incident CVD, including coronary disease and stroke events, were assessed with Cox proportional hazards models. The mean±SD office, morning home, and nighttime home systolic BP (SBP)/diastolic BP were 140±15/82±10, 137±15/79±10, and 121±15/70±9 mm Hg, respectively. During a follow-up of 7.1±3.8 years (18,116 person-years), 152 CVD events occurred. A 10-mm Hg increase of nighttime home SBP was associated with an increased risk of CVD events (hazard ratios [95% CIs]: 1.201 [1.046-1.378]), after adjustments for covariates including office and morning home SBPs. The model fit assessed by the change in Goodness-of-Fit was improved when we added nighttime home SBP into the base models including office and morning home SBPs (Δ6.838 [5.6%]; P=0.009). This is among the first and largest nationwide practice-based study demonstrating that nighttime SBP obtained using a home device is a predictor of incident CVD events, independent of in-office and morning in-home SBP measurement. Clinical Trial Registration- URL: http://www.umin.ac.jp/icdr/index.html . Unique identifier: UMIN000000894.

Identifiants

pubmed: 31006331
doi: 10.1161/HYPERTENSIONAHA.118.12740
pmc: PMC6510323
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1240-1248

Références

Hypertension. 2012 Oct;60(4):921-8
pubmed: 22892810
Hypertens Res. 2007 Aug;30(8):707-12
pubmed: 17917318
J Clin Hypertens (Greenwich). 2015 May;17(5):340-8
pubmed: 25689113
Hypertension. 2016 Jul;68(1):54-61
pubmed: 27160200
Hypertension. 2001 Oct;38(4):852-7
pubmed: 11641298
Circulation. 2005 Apr 12;111(14):1777-83
pubmed: 15809377
J Hypertens. 1992 Dec;10(12):1531-5
pubmed: 1338085
Hypertension. 2018 Jun;71(6):e13-e115
pubmed: 29133356
Eur Heart J. 2018 Sep 1;39(33):3021-3104
pubmed: 30165516
J Clin Hypertens (Greenwich). 2019 Apr;21(4):463-469
pubmed: 30609129
Blood Press Monit. 2018 Dec;23(6):318-326
pubmed: 30418253
Hypertens Res. 2014 Apr;37(4):253-390
pubmed: 24705419
Blood Press Monit. 2001 Aug;6(4):203-5
pubmed: 11805470
J Hypertens. 2019 May;37(5):905-916
pubmed: 30394982
Hypertens Res. 2012 Aug;35(8):777-95
pubmed: 22863910
J Hypertens. 2014 Jan;32(1):82-9
pubmed: 24326992
J Hypertens. 2002 Nov;20(11):2183-9
pubmed: 12409956
J Hypertens. 2016 Mar;34(3):438-44; discussion 444
pubmed: 26727487
Prog Cardiovasc Dis. 2016 Nov - Dec;59(3):262-281
pubmed: 27080202
Hypertension. 2016 Apr;67(4):693-700
pubmed: 26902495
Circ J. 2017 Jun 23;81(7):948-957
pubmed: 28321001
J Clin Hypertens (Greenwich). 2019 Jun;21(6):853-858
pubmed: 30803128
J Clin Hypertens (Greenwich). 2018 Oct;20(10):1527-1535
pubmed: 30246286
J Hypertens. 2018 Feb;36(2):243-249
pubmed: 28915229
J Clin Hypertens (Greenwich). 2018 Nov;20(11):1633-1641
pubmed: 30350337
J Hypertens. 2008 Aug;26(8):1505-26
pubmed: 18622223
Lancet. 2007 Oct 6;370(9594):1219-29
pubmed: 17920917
Hypertension. 2005 Jan;45(1):142-61
pubmed: 15611362
Hypertension. 2008 Jul;52(1):10-29
pubmed: 18497370
Hypertension. 2018 Jun;71(6):997-1009
pubmed: 29712746
J Hypertens. 2013 Sep;31(9):1731-68
pubmed: 24029863

Auteurs

Kazuomi Kario (K)

From the Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine (JMU), Tochigi, Japan (K.K., H.K., N.T., T.F., S.H.).
JMU Center of Excellence, Community Medicine Cardiovascular Research and Development (JCARD), Tochigi, Japan (K.K., N.T., T.F., Y.Y., S.H.).

Hiroshi Kanegae (H)

From the Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine (JMU), Tochigi, Japan (K.K., H.K., N.T., T.F., S.H.).
Genki Plaza Medical Center for Health Care, Tokyo, Japan (H.K.).

Naoko Tomitani (N)

From the Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine (JMU), Tochigi, Japan (K.K., H.K., N.T., T.F., S.H.).
JMU Center of Excellence, Community Medicine Cardiovascular Research and Development (JCARD), Tochigi, Japan (K.K., N.T., T.F., Y.Y., S.H.).

Yukie Okawara (Y)

JMU Center of Global Home and Ambulatory BP Analysis (GAP), Tochigi, Japan (Y.O.).

Takeshi Fujiwara (T)

From the Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine (JMU), Tochigi, Japan (K.K., H.K., N.T., T.F., S.H.).
JMU Center of Excellence, Community Medicine Cardiovascular Research and Development (JCARD), Tochigi, Japan (K.K., N.T., T.F., Y.Y., S.H.).

Yuichiro Yano (Y)

JMU Center of Excellence, Community Medicine Cardiovascular Research and Development (JCARD), Tochigi, Japan (K.K., N.T., T.F., Y.Y., S.H.).

Satoshi Hoshide (S)

From the Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine (JMU), Tochigi, Japan (K.K., H.K., N.T., T.F., S.H.).
JMU Center of Excellence, Community Medicine Cardiovascular Research and Development (JCARD), Tochigi, Japan (K.K., N.T., T.F., Y.Y., S.H.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH